UCB - SCHULD

Aktienkurs
238.60
Täglich Wechseln
-0.40 -0.17%
Monatlich
-6.03%
Jährlich
59.39%
Q2 Prognose
233.96




SCHULD Veränderung Datum
Alcon AG USD 509M 4.74B 2025-12
Almirall EUR 342.86M 61.94M 2025-12
Amarin USD 0 0 2025-03
argenx SE USD 43.15M 4.1M 2025-06
AstraZeneca USD 32.63B 207M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
Galapagos EUR 7.5M 3.36M 2025-09
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 17.75B 396M 2025-09
GRIFOLS EUR 8.82B 1.23B 2025-06
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.1B 2.7B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Orion EUR 305.4M 15.8M 2025-12
Recordati EUR 2.5B 33.23M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
UCB EUR 3.03B 12M 2024-12
Unibail Rodamco EUR 27.56B 297.9M 2024-12